Nurse Practitioner, Gerontology · Jackson, MS
NPI
1306350129
Since 2017
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
350 W Woodrow Wilson Ave # 411
Jackson, MS, 39213
Phone (601) 432-3237
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,872
48 services
Medicare patients, 2024
25
Average age 59
Drug cost, 2024
$2.9M
1,626 prescriptions
Company payments, 2025
$146
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tamika M Broome was code 99214 (office e&m - established), 38 times for 20 patients. In total Tamika M Broome billed 48 services in 4 codes, and Medicare paid $1,872.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 38 | 20 | $44.35 | $1,685 |
By year: 2022 $4,667 for 115 services; 2023 $2,790 for 72 services; 2024 $1,872 for 48 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tamika M Broome prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 434 prescriptions and refills. In total Tamika M Broome wrote 1,626 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 434 | 434 | 41 | $1.6M |
| Atorvastatin Calcium Generic | 101 | 160 | 15 | $607 |
| Tivicay Dolutegravir Sodium | 78 | 78 | Under 11 | $196K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 62 | 62 | Under 11 | $226K |
| Rosuvastatin Calcium Generic | 60 | 92 | Under 11 | $440 |
| Descovy Emtricitabine/Tenofov Alafenam | 52 | 52 | Under 11 | $105K |
| Juluca Dolutegravir/Rilpivirine | 49 | 49 | Under 11 | $160K |
| Amlodipine Besylate Generic | 43 | 81 | Under 11 | $108 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 35 | 35 | Under 11 | $129K |
| Hydrochlorothiazide Generic | 30 | 44 | Under 11 | $40.61 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 27 | 29 | Under 11 | $97.6 |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 25 | 35 | Under 11 | $3,953 |
| Metformin Hcl Er Metformin Hcl | 25 | 25 | Under 11 | $180 |
| Furosemide Generic | 25 | 25 | Under 11 | $53.76 |
| Ritonavir Generic | 25 | 35 | Under 11 | $2,979 |
Brand drugs: 930 claims; generic drugs: 696 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tamika M Broome $146 ($146 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.